Joshua W. Osbun

Joshua W. Osbun, MD

Top Doctors®

Specializes In
  • Neurosurgery
Languages Spoken
  • English


Sees Patients For

Open surgical and endovascular treatment of cerebrovascular disease and complex tumors of the skull base. special expertise in clipping, coiling and flow diversion for brain aneurysms, surgical resection and embolization of brain arteriovenous malformations and dural arteriovenous fistulas, the surgical treatment of cavernous malformation, meningioma, and moya-moya disease, carotid stenting and carotid endarterectomy for carotid artery stenosis, and mechanical thrombectomy for acute ischemic stroke

Hospital Affiliations

  • Barnes-Jewish Hospital
  • Missouri Baptist Medical Center
  • St. Louis Children's Hospital



Academic Title(s)

Associate Professor of Neurosurgery, Radiology and Neurology
Program Director, Neurosurgery Residency
Director, Cerebrovascular Surgery and Interventional Neuroradiology

Research Interests

Clinical outcome measures in the surgical, endovascular and medical treatment of cerebrovascular disease, and new device development and evaluation for use in interventional neuroangiography techniques

Publications & Research

View research profile »



2016 Cerebrovascular & Interventional Neuroradiology,Emory University, Atlanta, Georgia,

Specialist Registrar in Neurosurgery

2011 Atkinson Morley & St. George’s Hospital,London, United Kingdom,


2014 Neurological Surgery,University of Washington, Seattle, Washington,

Medical Degree

2007 University of Texas Southwestern Medical Center,Dallas, Texas,

Bachelor of Arts

2002 Texas A & M University,College Station, Texas,

Financial Disclosures
  • Medtronic
    • Consulting/Advisory Board: $1 - $9,999
    • Speaker Fees: $10,000 - $19,999
    • Reporting Date: 05/01/2023

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.